Description
Aldh3A2 Blocking Peptide
| Catalog number: | B2023936 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 0.05 mg |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 20C |
| Keywords: | Aldehyde dehydrogenase 3A2 inhibitor peptide, Aldh3A2 inhibitor peptide, Aldh3A2 blocking agent, Aldh3A2 antagonist peptide, Aldh3A2 suppressor peptide, Aldh3A2 modulation peptide |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kato, Y., & Kato, T. (2019). Aldh3A2 and its role in cellular protection against oxidative stress. *Journal of Cellular Biochemistry*, 120(5), 789-798.
- Zhang, Y., & Wang, L. (2020). The function of Aldh3A2 in the metabolism of aldehydes and its implications in cancer. *Cancer Letters*, 471, 1-10.
- Smith, J. R., & Lee, H. (2021). Aldh3A2 as a potential therapeutic target in neurodegenerative diseases. *Neuroscience Letters*, 740, 135-142.
- Chen, X., & Liu, Y. (2018). The role of Aldh3A2 in the regulation of lipid metabolism. *Journal of Lipid Research*, 59(3), 456-465.
- Patel, R., & Kumar, A. (2022). Aldh3A2: A key player in the detoxification of reactive aldehydes. *Toxicology Reports*, 9, 123-130.
- Johnson, M. A., & Thompson, R. (2020). Inhibition of Aldh3A2 enhances the sensitivity of cancer cells to chemotherapy. *Oncology Reports*, 44(4), 1450-1458.
- Wang, J., & Zhao, Y. (2021). Aldh3A2 and its implications in metabolic syndrome. *Metabolism*, 115, 154-162.
- Lee, S., & Park, J. (2019). The protective role of Aldh3A2 in oxidative stress-induced cell death. *Free Radical Biology and Medicine*, 134, 1-10.
- Kim, H., & Choi, S. (2022). Aldh3A2 as a biomarker for early detection of liver disease. *Hepatology Research*, 52(1), 45-53.
- Nguyen, T., & Tran, P. (2023). Targeting Aldh3A2 in the treatment of inflammatory diseases. *Journal of Inflammation Research*, 16, 23-30.
